stock.name

Exact Sciences Corp.

EXAS

Market Cap$9.98B
Close$

Compare Exact Sciences

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Exact Sciences Corp.Exact Sciences Corp.-41.50%-8%3.80.8
marketMarket Avg53.91.27%26%-1.2
HealthcareHealthcare Avg30.31.33%16%7.51.3
$85.00

Target Price by Analysts

70.5% upsideExact Sciences Target Price DetailsTarget Price
$72.07

Current Fair Value

44.6% upside

Undervalued by 44.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.98 Billion
Enterprise Value$11.69 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.33
Beta1.58
Outstanding Shares184,529,721
Avg 30 Day Volume3,424,740

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-41.54
PEG-85.38
Price to Sales3.83
Price to Book Ratio3.12
Enterprise Value to Revenue4.61
Enterprise Value to EBIT-36.8
Enterprise Value to Net Income-49
Total Debt to Enterprise0.2
Debt to Equity0.76

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Exact Sciences Corp.

CEO: Kevin Conroy